Latest filing published 23 Feb 2021 for ExpreS2ion Biotech Holding AB (EXPRS2), €2,440.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -47.0%Entry 548.65 · Close at T+365 290.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gitte Pedersen-Botero: trading record in brief
This profile gathers the share dealings of Gitte Pedersen-Botero across 2 companies, led by ExpreS2ion Biotech Holding AB and ExpreS2ion Biotech Holding AB (EXPRS2). Between 14 July 2020 and 15 January 2021, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 1 purchase worth €2,440. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2021, the count stands at 1 purchase and no sales.
The newest entry dates from 23 February 2021: an open-market purchase of €2,440, in ExpreS2ion Biotech Holding AB (EXPRS2). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gitte Pedersen-Botero
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,700 shares@ SEK 14.50100.0% of flowAktieISIN SE0008348262FI:csv-5467cbb7ccf5012089e8Canonical exit: 15 Apr 2021 (T+90)
- 25,200 shares@ SEK 6.96100.0% of flowAktieISIN SE0008348262FI:csv-1905fae74affbeb0cf4c
2 of 2 declarations